Cowen And Company, LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $1.22 Million - $1.67 Million	-26,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $232,350 - $319,650	5,000 Added 23.81%	26,000 $47,000
Q1 2021 May 04, 2021	BUY	$55.47 - $72.35 $1.16 Million - $1.52 Million	21,000 New	21,000 $32,000
Q4 2020 Feb 08, 2021	SELL	$38.38 - $71.11 $932,634 - $1.73 Million	-24,300 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$27.2 - $42.19 $427,040 - $662,383	-15,700 Reduced 39.25%	24,300 $18,000
Q2 2020 Aug 13, 2020	BUY	$22.22 - $35.69 $888,800 - $1.43 Million	40,000 New	40,000 $277,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.